Odonate Therapeutics, Inc. (ODT): IPOs News

ODT – Odonate Therapeutics has priced an upsized 6.25M shares at a low-end price of $24.00.

Key Facts Surrounding This News Item

  • ODT had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Odonate Therapeutics, Inc. (ODT)

Odonate Therapeutics, LLC develops therapeutics to enhance the lives of patients with cancer in the United States. It is developing Tesetaxel, a novel chemotherapy agent that has completed Phase II clinical trials for patients with advanced or metastatic breast cancer. The company was founded in 2013 and is based in San Diego, California. View our full ODT ticker page with ratings, news, and more.

ODT at a Glance

ODT Current POWR Rating™
Overall POWR Rating™
ODT Current Price $16.51 0.06%
More ODT Ratings, Data, and News

ODT Price Reaction

The day of this event (Dec. 6, 2017)
ODT Closing Price0.00 N/A%
ODT Volume0
N/A% from avg
Leading up to this event
ODT 1-mo returnN/A%

ODT Price Chart

More Odonate Therapeutics, Inc. (ODT) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ODT News
Page generated in 1.145 seconds.